Now showing items 1-6 of 6
A new syndrome of axial muscle rigidity associated with etretinate therapy A videotape segment accompanies this article.
(Wiley Subscription Services, Inc., A Wiley Company, 1988)
We report on three cases of a novel syndrome associated with treatment for psoriasis with the retinoid etretinate. The distinctive features of this syndrome include rigidity that is restricted to the axial muscles, impairment ...
Vesicular neurotransmitter transporters in Huntington's disease: Initial observations and comparison with traditional synaptic markers
(John Wiley & Sons, Inc., 2001-09-15)
Markers of identified neuronal populations have previously suggested selective degeneration of projection neurons in Huntington's disease (HD) striatum. Interpretations are, however, limited by effects of compensatory ...
Alzheimer's disease versus dementia with Lewy bodies: Cerebral metabolic distinction with autopsy confirmation
(John Wiley & Sons, Inc., 2001-09)
Seeking antemortem markers to distinguish Dementia with Lewy bodies (DLB) and Alzheimer's disease (AD), we examined brain glucose metabolism of DLB and AD. Eleven DLB patients (7 Lewy body variant of AD [LBVAD] and 4 pure ...
Striatal monoaminergic terminals in Lewy body and Alzheimer's dementias
(Wiley Subscription Services, Inc., A Wiley Company, 2002-06)
Vesicular monoamine transporter type 2 and benzodiazepine binding site expressions were examined with quantitative autoradiography in postmortem striata from 19 patients with dementia with Lewy bodies, seven patients with ...
Autoradiographic quantification of muscarinic cholinergic synaptic markers in bat, shrew, and rat brain
(Kluwer Academic Publishers-Plenum Publishers; Plenum Publishing Corporation ; Springer Science+Business Media, 1994-05)
We employed radioligand binding autoradiography to determine the distributions of pre- and postsynaptic cholinergic radioligand binding sites in the brains of two species of bat, one species of shrew, and the rat. High ...
Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging
(Wiley Subscription Services, Inc., A Wiley Company, 1996-12)
We present development and human application of a method for determining the regional cerebral density of the type 2 vesicular monoamine transporter (VMAT2) using positron emission tomography (PET) and [ 11 C]dihydrotetrabenazine ...